Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two doses of ropivacaine in penile block for circumcision
PACTR202308600418875Recruiting
- Sponsor
- Faculty of Medicine of Sousse
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of ropivacaine (2 arms), sponsored by Faculty of Medicine of Sousse. Primary endpoint: Postoperative pain. Started May 2023; status: recruiting.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on PACTR202308600418875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308600418875.